MedTrace Logo

Lactoferrin and Lysozyme Supplementation for Environmental Enteric Dysfunction

NCT02925026 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 235

Last updated 2018-05-02

No results posted yet for this study

Summary

Randomized, double-blind, placebo controlled trial of daily lactoferrin and lysozyme supplementation in improving environmental enteric dysfunction in Malawian children

Conditions

  • Environmental Enteric Dysfunction

Interventions

DIETARY_SUPPLEMENT

Lactoferrin

DIETARY_SUPPLEMENT

Lysozyme

DIETARY_SUPPLEMENT

Placebo

Sponsors & Collaborators

  • University of Malawi

    collaborator OTHER

  • Washington University School of Medicine

    lead OTHER

Principal Investigators

  • Mark J Manary, MD · Washington University in St. Louis; University of Malawi

  • Chrissie Thakwalakwa, PhD · Study Director

  • Indi Trehan, MD MPH DTM&H · Washington University in St. Louis; University of Malawi

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
12 Months
Max Age
35 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • Malawi

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02925026 on ClinicalTrials.gov